[Allergic rhinitis].
1.
The prevalence of allergy is estimated from 15 to 35%, incidence is on the rise. 2.


METHODS
Allergy is initiated by a very specific IgE-dependent mechanism, but involves a late phase corresponding to non-specific inflammation. 3.
"Modern" antihistamines and local intranasal corticosteroid therapy constitute the basis of symptomatic treatment.
Crampette
L
L
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D003430:Cross-Sectional Studies; D003888:Desensitization, Immunologic; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D018836:Inflammation Mediators / Q000097:blood; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy / Q000453:epidemiology* / Q000276:immunology
D018926:Anti-Allergic Agents; D018836:Inflammation Mediators; D007073:Immunoglobulin E